Pediatric patients with focal-onset seizures experienced significant reductions in their 24-hour seizure rates compared to placebo when administered adjunctive 14 mg/kg per day pregabalin (Lyrica; Pfizer).
Drs Robert J. Fox and Fred D. Lublin conclude a discussion on the management of relapsing multiple sclerosis by highlighting best practices in community settings to better optimize care for patients.
Join Mitzi J. Williams, MD, for a discussion of the latest best practice guidance and real-world cases of COVID-19 in patients with multiple sclerosis.
